Practice
Open Access
Using intranasal corticosteroids
James Fowler and Leigh J Sowerby
CMAJ January 11, 2021 193 (2) E47; DOI: https://doi.org/10.1503/cmaj.201266
James Fowler
Department of Otolaryngology–Head and Neck Surgery, Western University, London, Ont.
MDLeigh J Sowerby
Department of Otolaryngology–Head and Neck Surgery, Western University, London, Ont.
MDData supplements
Online appendix
Related Articles
- Fowler, J., & Sowerby, L. J. (2021). Utilisation des corticostéroïdes intranasaux. CMAJ, 193(11), E399-E400. Accessed May 07, 2024. https://doi.org/10.1503/cmaj.201266-f.
- Kline, G. A., Symonds, C. J., & Holmes, D. T. (2021). Systemic absorption of intranasal corticosteroids may occur and can potentially affect the hypothalamic–pituitary–adrenal axis. CMAJ, 193(12), E426. Accessed May 07, 2024. https://doi.org/10.1503/cmaj.78162.
In this issue
Article tools
Respond to this article
Using intranasal corticosteroids
James Fowler, Leigh J Sowerby
CMAJ Jan 2021, 193 (2) E47; DOI: 10.1503/cmaj.201266
Jump to section
- Article
- Intranasal corticosteroids can be used as primary or adjunct therapy for many inflammatory conditions within the nasal cavity
- There are 9 intranasal corticosteroids approved in Canada, all with similar efficacy
- Intranasal corticosteroids are safe, but local adverse effects are common
- Correct administration of intranasal corticosteroids is crucial for desired therapeutic effect
- Fewer intranasal corticosteroids are available for children and pregnant women
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics